Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
May prompt metabolic screening in NAFLD; leaves open prospective trials on causality and interventions.
Non-alcoholic fatty liver disease has been associated with metabolic disorders, including central obesity, dyslipidemia, hypertension and hyperglycemia. Metabolic syndrome, obesity, and insulin resistance are major risk factors in the pathogenesis of non-alcoholic fatty liver disease. Non-alcoholic fatty liver disease refers to a wide spectrum of liver damage, ranging from simple steatosis to non-alcoholic steatohepatitis, advanced fibrosis and cirrhosis.
No takes yet. Share an insight, caveat, or question.
Tarantino et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: